Compugen(CGEN)
Search documents
Compugen(CGEN) - 2022 Q3 - Earnings Call Transcript
2022-11-15 06:14
Compugen Ltd. (NASDAQ:CGEN) Q3 2022 Earnings Conference Call November 14, 2022 8:30 AM ET Company Participants Yvonne Naughton - Head, Investor Relations and Corporate Communications Anat Cohen-Dayag - President and Chief Executive Officer Henry Adewoye - Chief Medical Officer Eran Ophir - Senior Vice President, Research and Drug Discovery Alberto Sessa - Chief Financial Officer Conference Call Participants Stephen Willey - Stifel Mark Breidenbach - Oppenheimer Reni Benjamin - JMP Securities Daina Graybosch ...
Compugen(CGEN) - 2022 Q2 - Earnings Call Transcript
2022-08-05 03:25
Compugen Ltd. (NASDAQ:CGEN) Q2 2022 Earnings Conference Call August 4, 2022 8:30 AM ET Company Participants Yvonne Naughton - Head of IR and Corporate Communications Anat Cohen-Dayag - President & CEO Ari Krashin - Chief Financial & Operating Officer Henry Adewoye - Chief Medical Officer Eran Ophir - Vice President Research & Drug Discovery Conference Call Participants Bonnie Quach - Stifel Mark Breidenbach - Oppenheimer Tony Butler - Roth Capital Daina Graybosch - SVB Leerink Reni Benjamin - JMP Securities ...
Compugen(CGEN) - 2021 Q4 - Annual Report
2022-02-27 16:00
UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 _________________________________________________ FORM 20-F ☐ REGISTRATION STATEMENT PURSUANT TO SECTION 12(b) OR (g) OF THE SECURITIES EXCHANGE ACT OF 1934 OR ☒ ANNUAL REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the fiscal year ended December 31, 2021 OR ☐ TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 OR ☐ SHELL COMPANY REPORT PURSUANT TO SECTION 13 OR 15( ...
Compugen(CGEN) - 2021 Q4 - Earnings Call Transcript
2022-02-24 17:56
Compugen Ltd. (NASDAQ:CGEN) Q4 2021 Results Conference Call February 24, 2022 8:30 AM ET Company Participants Anat Cohen-Dayag - President and CEO Yvonne Naughton - Head of Investor Relations and Corporate Communications Henry Adewoye - Chief Medical Officer Ari Krashin - Chief Financial and Operating Officer Eran Ophir - Vice President Research & Drug Discovery Conference Call Participants Stephen Willey - Stifel Reni Benjamin - JMP Securities Tony Butler - ROTH Capital Daina Graybosch - SVB Leerink Operat ...
Compugen(CGEN) - 2021 Q3 - Earnings Call Transcript
2021-11-12 18:51
Compugen Ltd. (NASDAQ:CGEN) Q3 2021 Earnings Conference Call November 12, 2021 ET Company Participants Anat Cohen-Dayag – President and CEO Yvonne Naughton – Head of Investor Relations and Corporate Communications Henry Adewoye – Chief Medical Officer Ari Krashin – Chief Financial and Operating Officer Eran Ophir – Vice President Research & Drug Discovery Conference Call Participants Mark Breidenbach – Oppenheimer Stephen Willey – Stifel Daina Graybosch – SVB Chris Howerton – Jefferies Tony Butler – ROTH Ca ...
Compugen(CGEN) - 2021 Q2 - Earnings Call Transcript
2021-07-28 19:10
Compugen Ltd (NASDAQ:CGEN) Q2 2021 Earnings Conference Call July 28, 2021 8:30 AM ET Company Participants Yvonne Naughton - Head, Investor Relations & Corporate Communication. Anat Cohen-Dayag - CEO, President & Director Ari Krashin - Chief Financial & Operating Officer Eran Ophir - VP, Research & Drug Discovery Henry Adewoye - SVP & Chief Medical Officer Conference Call Participants Mark Breidenbach - Oppenheimer Chris Howerton - Jefferies Reni Benjamin - JMP Securities Asthika Goonewardene - Truist Securi ...
Compugen (CGEN) Presents At TIGIT Pathway:Deep Dive in Cancer Immunotherapy Targets - Slideshow
2021-06-30 19:52
TGOM FROM CODE TO CURE® THE TIGIT PATHWAY PVRIG, a Novel Pathway Member Ta r g e t s f o r C a n c e r I m m u n o t h e r a p y : A D e e p D i v e E r a n O p h i r, V P R e s e a r c h & D r u g D i s c o v e r y J u n e 2021 T h e D N A M-1 A x i s • DNAM-1 axis plays an essential role in tumor immunology • PVRIG binds PVRL2 as a functional ligand (TIGIT has a low affinity for PVRL2) 中 • DNAM-1 axis – two parallel dominant complementary inhibitory pathways (PVRIG & TIGIT/CD96?) • TIGIT and PVRIG deliver ...
Compugen(CGEN) - 2021 Q1 - Earnings Call Transcript
2021-05-13 18:34
Compugen Ltd. (NASDAQ:CGEN) Q1 2021 Earnings Conference Call May 13, 2021 8:30 AM ET | --- | |------------------------------------------------------------------------| | | | Company Participants | | Anat Cohen-Dayag - CEO | | Ari Krashin - CFO and COO | | Henry Adewoye - Chief Medical Officer | | Conference Call Participants | | Mark Breidenbach - Oppenheimer Stephen Willey - Stifel | | Daina Graybosch - SVB Leerink | | | | Ren Benjamin - JMP Securities Asthika Goonewardene - Truist Securities | | | | Roger ...
Compugen(CGEN) - 2020 Q4 - Earnings Call Transcript
2021-02-25 22:50
Compugen Ltd. (NASDAQ:CGEN) Q4 2020 Earnings Conference Call February 25, 2021 8:30 AM ET Company Participants Elana Holzman - Director, IR and Corporate Communications Anat Cohen-Dayag - President and CEO Henry Adewoye - SVP and CMO Ari Krashin - CFO and COO Eran Ophir - VP, Research and Drug Discovery Conference Call Participants Chris Howerton - Jefferies Stephen Willey - Stifel Mark Breidenbach - Oppenheimer Reni Benjamin - JMP securities Asthika Goonewardene - Truist Securities Tony Butler - ROTH Capit ...
Compugen(CGEN) - 2020 Q4 - Annual Report
2021-02-24 16:00
UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 _________________________________________________ ____________________________________ ___________________________________________________________ ________________________________________________ ________________________________________________ FORM 20-F ☐ REGISTRATION STATEMENT PURSUANT TO SECTION 12(b) OR (g) OF THE SECURITIES EXCHANGE ACT OF 1934 OR ☒ ANNUAL REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 193 ...